[Protein C and plasma serine protease inhibitors in patients with essential hypertension].
Plasma protein C and serine protease inhibitors together with some other hemostasis parameters have been determined in 60 patients with essential hypertension. Significant decrease in protein C and alpha 2-antiplasmin levels, increased fibrinogen, fibrinopeptide A, WF: Ag, plasminogen, and prolongation of euglobulin fibrinolysis time have been observed. Results indicate hypercoagulability and fibrinolysis defect in hypertensive patients.
Kłoczko
J
J
Kliniki Hematologii AM w Białymstoku.
Bielawiec
M
M
Galar
M
M
Czaczkowska
T
T
Wojtukiewicz
M
M
D000328:Adult; D006801:Humans; D006973:Hypertension / Q000097:blood*; D008875:Middle Aged; D011486:Protein C / Q000378:metabolism*; D012016:Reference Values; D015842:Serine Proteinase Inhibitors / Q000097:blood*
D011486:Protein C; D015842:Serine Proteinase Inhibitors
Białko C oraz osoczowe inhibitory proteaz serynowych u chorych na samoistne nadciśnienie tetnicze.